Research.Patient.info
Chronic Inflammatory Demyelinating Polyradiculoneuropathy research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
This study is testing a new medicine, riliprubart, for people with a long-term nerve condition called CIDP. It's for those who haven't improved with usual treatments. We want to see if riliprubart is safe and helps improve symptoms compared to a dummy medicine.
United States · Argentina · Belgium - enrolling by invitationPHASE3
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
This study looks at the long-term safety and effectiveness of a treatment called riliprubart for adults with a nerve condition called CIDP. It's for people who have already been in other riliprubart studies and want to continue treatment.
United States · Argentina · Brazil